RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Songqing Capital
S

Songqing Capital portfolio

Songqing Capital has 1 portfolio company on record at Recent Funding, with 2 investments in the last 12 months.

Type: Investor.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 2.
Capital in their rounds: $100M.
Latest deal: Phrontline Biopharma · Nov 12, 2026.
About this page

Its most recent investment on record is Phrontline Biopharma's $40M Series A round in November 2026, alongside Xiamen C&D Corporation, Oriza Holdings, Decheng Capital and 3 others. That company is in Health and bio. It has co-invested with Decheng Capital, Jifeng Capital and Med-Fine Capital, most often Decheng Capital (2 rounds).

What Songqing Capital invests in

How Songqing Capital invests

StageDealsCapital in rounds
Series A 1 50%$40M
Seed 1 50%$60M
YearDealsCapital in rounds
2025 1 50%$60M
2026 1 50%$40M

Songqing Capital portfolio companies

CompanyRound with Songqing CapitalTotal raisedLatest raise
PPhrontline Biopharma
Health and bio
 Series A · $40M$100MNov 12, 2026
Series A

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 2 rounds on Recent Funding that name Songqing Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Songqing Capital, which is a subset of its real portfolio. API: /api/v1/investors/songqing-capital (get a free API key). More: the most active VC firms and new venture capital funds.